CARE Ratings has released its monitoring report for Aequs Limited regarding its Pre-IPO and IPO proceeds for the quarter ending September 30, 2026. While the agency confirmed no material deviations, it flagged instances of fund parking in subsidiary accounts and minor excess expenditure on capital equipment without prior board approval. Additionally, the report noted instances of fund commingling for general corporate purposes. These observations highlight procedural gaps in how proceeds are being managed compared to the initial offer document.
Aequs Limited Monitoring Report: Key Utilization Findings
- IPO Proceeds Utilization Variance: Rs 8.49 crore vs. Rs 8.11 crore budget.
- Unutilized Funds Parked in Subsidiary Accounts: Rs 23.34 crore total across Pre-IPO and IPO.
Reader Takeaway: CARE Ratings reports no material deviations, though procedural gaps in fund parking and unapproved capital expenditure were identified.
What just happened
CARE Ratings, acting as the monitoring agency for Aequs Limited, has issued its report for the quarter ended September 30, 2026. The report reviews the deployment of funds raised through the company’s Rs 144 crore Pre-IPO placement and its Rs 670 crore IPO. The agency confirmed that there are no material deviations from the objects stated in the offer documents.
Why this matters
For investors, the monitoring report serves as a transparency check to ensure capital raised is used exactly as promised. The agency identified a specific variance where Rs 8.49 crore was spent on machinery and equipment, exceeding the budgeted Rs 8.11 crore. The report notes that formal board approval for this specific excess expenditure is currently pending.
Funds and Operational Observations
The agency flagged two procedural areas of concern regarding the handling of unutilized funds. First, Rs 5.15 crore from the Pre-IPO round and Rs 18.19 crore from the IPO were parked in the bank accounts of the company’s subsidiaries, an arrangement not explicitly detailed in the original offer document. Second, the report highlighted instances of fund commingling, noting that subsidiary current accounts—used for general corporate purposes—were also being utilized for various other operational transactions.
What to track next
Investors should monitor future disclosures to see if the company regularizes the excess capital expenditure through board ratification and how it aligns its treasury management practices with the stipulations outlined in the prospectus.